Cystic fibrosis treatments are improving patients’ quality of life. Three physicians from University of Iowa Health Care share more about cystic fibrosis.

The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...

Performance Institute lodges nearly 30-point appeal with MMA South Africa over controversial EFC 131 main event involving Luke Michael and Diego Bandu, citing illegal strikes, officiating errors, and ...